However, tumours that have a deficiency in MSH6 often do not show instability in dinucleotide repeats and therefore risk being classified as MSI-L or even MSS when analysed with the NCI panel containing only two potentially unstable mononucleotide repeats (Verma et al, 1999; Wu et al, 1999). The gene discussed is MSH6; the disease is neoplasm.